白云山：12月1日召开董事会会议

Company Overview - Baiyunshan (SH 600332) announced on December 1 that its 31st meeting of the 9th Board of Directors was held via telecommunication, where it reviewed proposals regarding the completion of fundraising investment projects and the permanent replenishment of working capital with surplus funds [1] Financial Performance - For the first half of 2025, Baiyunshan's revenue composition was as follows: large commercial accounted for 69.32%, large health for 16.79%, large traditional medicine for 12.53%, other businesses for 1.07%, and miscellaneous for 0.3% [1] - As of the report date, Baiyunshan's market capitalization stood at 42.1 billion yuan [1]